A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
Status:
Completed
Trial end date:
2019-11-06
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if nab-paclitaxel and carboplatin chemotherapy plus
necitumumab is effective and safe in participants with stage IV squamous non-small cell lung
cancer.